MYC and neoplasm: Moreover, consistent with our in vitro results, immunohistochemical staining of fresh tumor samples showed that the expression of MYC and ribosome biogenesis proteins were downregulated by BRQ monotherapy or combination with venetoclax (Fig. 6G-H, Figure S8F).